C.R. Bard Inc. (New Jersey) (BCR)

331.24
1.95 0.59
NYSE : Health Technology
Prev Close 333.19
Open 333.49
Day Low/High 331.24 / 334.03
52 Wk Low/High 223.02 / 337.73
Volume 4.71M
Avg Volume 610.90K
Exchange NYSE
Shares Outstanding 72.89M
Market Cap 24.14B
EPS 7.20
P/E Ratio 43.70
Div & Yield 1.00 (0.00%)
Charts Paint a Disturbing Picture

Charts Paint a Disturbing Picture

Traders should be looking for shorting opportunities.

CR Bard upgraded at JP Morgan

CR Bard downgraded at JP Morgan

CR Bard upgraded at Morgan Stanley

Cramer: Oil-and-Gas vs. Everything Else

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

Some Stocks to Watch Today

Though broad futures have improved somewhat. Market futures are still pointing to a down open, but they have improved somewhat since my first Diary post this morning. Meantime, oil just can't get any love. The International Energy Agency (IEA) has c...

Cramer: Stocks That Stand Out

There's a powerful collection of "what's working."

A Strategy Proven Over the Long Term

These stocks are all worth your consideration.

The Next Deals Are in Hospital

A wave of M&A in the health sector makes sense.

C.R. Bard downgraded at Barclays

CR Bard downgraded at BofA/Merrill

CR Bard downgraded at JP Morgan

CR Bard upgraded at Piper

CR Bard upgraded at Goldman

Buying Stocks by the Basket

Buying Stocks by the Basket

These 15 stocks have similar price patterns and technical setups.

Paying Up for Quality

For most investors, this simple strategy is the way to go.

Barge Into Bard, Microsoft Shares

Barge Into Bard, Microsoft Shares

James Barksdale, portfolio manager for EIC Value Fund, names his favorite stocks including Microsoft, Wells Fargo and CR Bard.

C.R. Bard Illustrates a Point

C.R. Bard Illustrates a Point

Occasionally there is unusual technical synchronization on multiple timeframes.

C.R. Bard downgraded at Goldman

Stocks Under $10: Chase This Winner?

Stocks Under $10: Chase This Winner?

Portfolio Mgr. David Peltier analyzes one of the early low-dollar winners of 2013.

CR Bard upgraded at BofA/Merrill

CR Bard downgraded at Morgan Stanley

CR Bard upgraded at JP Morgan

Stocks Under $5: Stealth Health Care Play

Stocks Under $5: Stealth Health Care Play

Portfolio Mgr. David Peltier uncovers a low-dollar healthcare stock with big growth potential.

CR Bard rated new Outperform at JMP

Stocks Under $10: At an Inflection Point

Stocks Under $10: At an Inflection Point

Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.

C.R. Bard downgraded at Jefferies

CR Bard upgraded at Goldman

CR Bard numbers boosted at Goldman

C.R. Bard target raised at Jefferies